These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9871576)

  • 1. Toward the antibody-catalyzed chemiluminescence. Design and synthesis of hapten.
    Sawa M; Imaeda Y; Hiratake J; Fujii R; Umeshita R; Watanabe M; Kondo H; Oda J
    Bioorg Med Chem Lett; 1998 Mar; 8(6):647-52. PubMed ID: 9871576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple reactive immunization towards the hydrolysis of organophosphorus nerve agents: hapten design and synthesis.
    Huang H; Han WG; Noodleman L; Grynszpan F
    Bioorg Med Chem; 2001 Dec; 9(12):3185-95. PubMed ID: 11711294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of an alpha,alpha-difluorophosphinate hapten for antibody-catalyzed hydrolysis of organophosphorus nerve agents.
    Vayron P; Renard PY; Valleix A; Mioskowski C
    Chemistry; 2000 Mar; 6(6):1050-63. PubMed ID: 10785826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of the hapten for the induction of antibodies catalyzing aldol reaction.
    Teraishi K; Saito M; Fujii I; Nakamura H
    J Mol Graph; 1994 Dec; 12(4):282-5, 292. PubMed ID: 7696219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody catalysis via strategic use of haptenic charge.
    Kikuchi K; Hilvert D
    Acta Chem Scand (Cph); 1996 Apr; 50(4):333-6. PubMed ID: 8639376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hapten design for the generation of catalytic antibodies.
    Thomas NR
    Appl Biochem Biotechnol; 1994; 47(2-3):345-72. PubMed ID: 7944348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural evidence for a programmed general base in the active site of a catalytic antibody.
    Golinelli-Pimpaneau B; Goncalves O; Dintinger T; Blanchard D; Knossow M; Tellier C
    Proc Natl Acad Sci U S A; 2000 Aug; 97(18):9892-5. PubMed ID: 10963661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure of the complex of a catalytic antibody Fab fragment with a transition state analog: structural similarities in esterase-like catalytic antibodies.
    Charbonnier JB; Carpenter E; Gigant B; Golinelli-Pimpaneau B; Eshhar Z; Green BS; Knossow M
    Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11721-5. PubMed ID: 8524836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The scope of antibody catalysis.
    Jacobsen JR; Schultz PG
    Curr Opin Struct Biol; 1995 Dec; 5(6):818-24. PubMed ID: 8749371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and syntheses of three haptens to generate catalytic antibodies that cleave amide bonds with nucleophilic catalysis.
    Ersoy O; Fleck R; Blanco MJ; Masamune S
    Bioorg Med Chem; 1999 Feb; 7(2):279-86. PubMed ID: 10218819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An investigation of antibody acyl hydrolysis catalysis using a large set of related haptens.
    Odenbaugh AL; Helms ED; Iverson BL
    Bioorg Med Chem; 2000 Feb; 8(2):413-26. PubMed ID: 10722164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward bifunctional antibody catalysis.
    Kikuchi K; Hannak RB; Guo MJ; Kirby AJ; Hilvert D
    Bioorg Med Chem; 2006 Sep; 14(18):6189-96. PubMed ID: 16782349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catalytic antibodies: hapten design strategies and screening methods.
    Xu Y; Yamamoto N; Janda KD
    Bioorg Med Chem; 2004 Oct; 12(20):5247-68. PubMed ID: 15388154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspects of antibody-catalyzed primary amide hydrolysis.
    Titmas RC; Angeles TS; Sugasawara R; Aman N; Darsley MJ; Blackburn G; Martin MT
    Appl Biochem Biotechnol; 1994; 47(2-3):277-90; discussion 291-2. PubMed ID: 7944343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical analysis of antibody catalysis.
    Hilvert D
    Annu Rev Biochem; 2000; 69():751-93. PubMed ID: 10966475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural convergence in the active sites of a family of catalytic antibodies.
    Charbonnier JB; Golinelli-Pimpaneau B; Gigant B; Tawfik DS; Chap R; Schindler DG; Kim SH; Green BS; Eshhar Z; Knossow M
    Science; 1997 Feb; 275(5303):1140-2. PubMed ID: 9027317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large rate accelerations in antibody catalysis by strategic use of haptenic charge.
    Thorn SN; Daniels RG; Auditor MT; Hilvert D
    Nature; 1995 Jan; 373(6511):228-30. PubMed ID: 7816136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A bait and switch hapten strategy generates catalytic antibodies for phosphodiester hydrolysis.
    Wentworth P; Liu Y; Wentworth AD; Fan P; Foley MJ; Janda KD
    Proc Natl Acad Sci U S A; 1998 May; 95(11):5971-5. PubMed ID: 9600901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of hapten binding and catalytic determinants in a family of catalytic antibodies.
    Ulrich HD; Schultz PG
    J Mol Biol; 1998 Jan; 275(1):95-111. PubMed ID: 9451442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of antibody and albumin catalyzed hydrolysis of steroidal p-nitrophenylcarbonates.
    Riva S; Mendozza M; Carrea G; Chattopadhyay P; Tramontano A
    Appl Biochem Biotechnol; 1998 Oct; 75(1):33-44. PubMed ID: 10214695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.